On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under‐reporting on odds ratios
- 19 June 2002
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 21 (14) , 2027-2044
- https://doi.org/10.1002/sim.1157
Abstract
A well‐known problem in spontaneous reporting systems (SRSs) for adverse drug reactions (ADRs) is under‐reporting, that is, the problem that not all occurrences of ADRs are reported to the SRS. We look at the question of how to draw statistical conclusions from analyses of SRS data using reporting odds ratios. We will show that certain under‐reporting problems play no role in assessing ADRs from SRSs: the results from the analyses turn out to be biased by some specific under‐reporting problems, but not by others. SRS data can be particularly useful for the assessment of drug–drug interactions. If the assumption holds that there is an under‐reporting problem for a first drug, and an under‐reporting problem for a second drug, but that these two under‐reporting problems do not influence each other, then reporting odds ratios estimated from SRSs are useful for signalling drug–drug interactions in the ADR‐experiencing population. Similar results hold for covariate–drug interactions. We illustrate our results using two examples. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 18 references indexed in Scilit:
- Attitudinal survey of voluntary reporting of adverse drug reactionsBritish Journal of Clinical Pharmacology, 1999
- Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting SystemThe American Statistician, 1999
- Signalling possible drug–drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazoleBritish Journal of Clinical Pharmacology, 1999
- Is reporting rate a good predictor of risks associated with drugs?British Journal of Clinical Pharmacology, 1999
- Non‐puerperal lactation associated with antidepressant drug useBritish Journal of Clinical Pharmacology, 1997
- Comparing reporting rates of adverse events between drugs with adjustment for year of marketing and secular trends in total reporting*Journal of Biopharmaceutical Statistics, 1995
- Alert systems for post‐marketing surveillance of adverse drug reactionsStatistics in Medicine, 1993
- Serum sickness-like reactions to cefaclorPublished by Elsevier ,1992
- Treatment of onychomycosis with terbinafineBritish Journal of Dermatology, 1992
- The detection of adverse reactions to therapeutic drugsStatistics in Medicine, 1982